Who we are
We are a network of clinicians, researchers, microbiologists, and engineers passionate about tackling the next existential threat to humanity
Chief Investigators
Adjunct Prof | Deputy Director of Phage Australia | Vice-President, Australasian Genomic Technologies Association | Business Development Lead, CIDM Westmead Institute | Genomic Chair, Scientific Advisory Committee of Westmead Research Precinct | Advocate for Women in STEMM | Career coach | GEDI member AAMRI
Senior lecturer in child and adolescent health, and paediatric infectious diseases specialist
ID clinician and clinical trialist with an interest in staphylococcal infections, skin infections, and general infectious diseases. Lead the SNAP and ASCOT clinical trials
Clinical microbiologist & ID Physician, SA Pathology & CALHN; Clinical Associate Professor University of Adelaide
Jennifer Byrne is Director of Biobanking with NSW Health Pathology and Professor of Molecular Oncology within the Faculty of Medicine and Health at the University of Sydney.
Trevor is a Research Fellow at Monash University, and the Director of the Centre to Impact AMR. His training is in molecular biology and microbiology.
Head, Airway Epithelial Research at Telethon Kids Institute and A/Prof at School of Population Health, Curtin University. His research looks to explore and test novel and repurposed therapeutics at the preclinical level using airways models from various respiratory disease settings.
Infectious Diseases and Microbiology and Director of the Department of Infectious Diseases at the Alfred Hospital and Monash University
Jeremy Barr is a senior lecturer and lab-head at Monash University, School of Biological Sciences. His research investigates the tri-partite interactions between bacteriophages and their bacterial and mammalian hosts.
Professor, School of Medical Sciences Director, Centre for Infectious Diseases and Microbiology (CIDM) Public Health, Sydney West LHD and Pathology West Faculty Member
Dr Hien Duong senior lecturer in pharmaceutical sciences at the University of Sydney Pharmacy school. She is an expert in polymer chemistry, organic and inorganic/organic hybrid nanomaterials. She has established herself as a leader in using nanotechnology in the form of nanoparticles for biomedical application.
Heejoon Myung is the founder and CEO of LyseNTech, a bactriophage company based in Korea.
I’m a scientist at Australia’s Government Research Agency with expertise in ML and genomics; adjunct A/Professor Macquarie University and AWS Hero. I have international keynotes, blogs, and YouTube activity and bring STEM expertise to boards.
Health Manager with over 10 years experience in research and clinical translation in the NSW health system. Experienced medical regulatory expert for medicines and biological therapies in Australia.
Partner Investigators
Clinical Microbiologist and Paediatric Infectious Diseases physician, PathWest Laboratory Medicine Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, University of Western Australia, Perth PhD student, University of Western Australia MB Bch BAO Sch MMED (Paeds) PgDip PID FRACP FRCPA
Director, Enterprise, International Partnerships and Clinical Trials, Office for Health and Medical Research, NSW Health
Sian is a Senior Policy Officer in the Advanced Therapeutics team in the Office for Health and Medical Research, NSW Health. She has a Bachelor of Science and a Bachelor of Laws. She is also an intellectual property lawyer with commercial and commercialisation experience in both private practice and within government.
Dr Natalie Twine is a Senior Research Scientist and leads the Genome Insights team at CSIRO. She is a recognised expert in the domains of translational genomics and genetics, cloud-computing and bioinformatics.
Dr Joey Lai, Advanced Genomics Specialist at the WIMR Genomics Facility. Over 10 years managing facility operations and providing Genomics expertise and services for by basic and clinical researchers at the Westmead Research Hub and beyond.
Head of Translational Vectorology Research Unit at CMRI with special interest in manufacturing and bioengineering of viral vectors
Staff Specialist; Director of Clinical Microbiologist and Infectious Diseases Specialist NSWHP RNSH; Pathology; Internal Medicine; Public Health Physician; Subject Matter Expert
I am a PI in the University and a leader of the IPTC which is a shared center of the University and Hadassah Medical Center. My lab is involved in all steps of isolation and characterization of phages. We currently have a collection of ~500 phages
ID consultant and clinical lead in the Israel phage therapy center, Chairman of the ESGNTA
Public Health Physician and Senior Medical Advisor to the NSW Office for Health and Medical Research
Amith Shetty is an Emergency physician, Clinical Director in the Patient Experience and System Performance Support division at NSW Ministry of Health and currently Clinical Lead for the NSW COVID-19 Care in Community program.
PhD in Medical Sciences. Biotechnology engineer. Head of the Laboratory for Molecular and Cellular Technology of the Queen Astrid Military Hospital (Brussels, Belgium). Senior scientist. Phage research. Cell therapy. Tissue engineering.
Senior scientist at Sciensano (Public Health Belgium), involved in various aspects of research and policy regarding antimicrobial resistance. Involved in the quality control of therapeutic phages in Belgium.
Full time respiratory researcher with an interest in environmental exposures and lung health, primarily from a pre-clinical/discovery perspective.
Life Science Industry professional, Managing Director of Decode Science, and industry partner of phage Australia
Associate Investigators
Student in the PhD direct-track program for honored students in the Hebrew university, guided by Prof. Ronen Hazan and Prof. Ran Nir-Paz
Postdoctoral Researcher/Research Coordinator; Chair of START Phage WA (WA Phage Task Force)
I aim to improve the health of people with respiratory diseases, particularly cystic fibrosis. I research how the lungs and immune system respond to different germs, for new insights into how chronic lung diseases begins and how we can intervene with new treatments.
Clinical Program Lead; Project Management; Infectious Diseases & Microbiology; Clinical Trials Coordinator; Biologics & Cellular Therapy Subject Matter Expert
I’m a researcher passionate about all things phages, particularly in the translation pipeline from bench to bedside. I’m currently doing my PhD, investigating the safety and potential of phage therapy against P. aeruginosa pulmonary infections.
OHMR Postdoctoral Fellow in Phage Therapy | Lead Scientist in Mycobacterium Phage Therapy at Westmead | Executive Committee of International Society for Viruses of Microorganisms | Developing innovative phage applications and therapeutics
Andrew is a PhD student fascinated by the interactions between phages and their hosts. His project is focused on phage resistance evolution by Pseudomonas aeruginosa.
Dr Venturini is an experienced microbiologist with clinical and basic science research expertise. She is a Postdoctoral Associate at the Sydney School of Veterinary Science, The University of Sydney.
Phage Research Team Leader at the Advanced Drug Delivery Group, Sydney Pharmacy School, University of Sydney